Title : Tacrolimus dose requirement based on the CYP3A5 genotype in renal transplant patients.

Pub. Date : 2017 Oct 6

PMID : 29113387






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Meanwhile, the dose of FK506 and CsA was recorded, blood concentration of the drugs was measured, and graft outcome was monitored.These results indicate that CYP3A5*AA/AG carriers need higher FK506 dose than CYP3A5*GG homozygote to achieve the target blood concentration. Cyclosporine cytochrome P450 family 3 subfamily A member 5 Homo sapiens
2 For CYP3A5*GG carriers, taking FK506 or CsA are both advisable. Cyclosporine cytochrome P450 family 3 subfamily A member 5 Homo sapiens
3 CYP3A5 genotyping is a new approach to detecting FK506 dose requirement and a predictive index for the FK506 or CsA treatment selection in kidney recipients. Cyclosporine cytochrome P450 family 3 subfamily A member 5 Homo sapiens